Are the T/C polymorphism of the CYP17 gene and the tetranucleotide repeat (TTTA) polymorphism of the CYP19 gene genetic markers for premature coronary artery disease in Caucasians?

Folia Biologica

Volumn 51, Issue 3, 2005, Pages 76-81

  Letonja, M ^a   Peterlin, B ^b   Bregar, D ^c   Petrovič, Daniel ^c  

^a General Hospital Ptuj   (Slovenia)

^b UNIVERSITY MEDICAL CENTRE LJUBLJANA   (Slovenia)

^c UNIVERSITY OF LJUBLJANA   (Slovenia)

Author keywords

Coronary artery disease association study; Genetic marker; T C polymorphism of the CYP17 gene; Tetranucleotide repeat (TTTA) polymorphism of the CYP19 gene

Indexed keywords

AROMATASE; CYTOCHROME P450C17; POLYNUCLEOTIDE; SEX HORMONE;

ADULT; ALLELE; ARTICLE; CAUCASIAN; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY RISK; CYP17 GENE; CYP19 GENE; FEMALE; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; LIPID METABOLISM; MAJOR CLINICAL STUDY; MALE; MARKER GENE; NUCLEOTIDE REPEAT; SEX DIFFERENCE;

EID: 22144438306     PISSN: 00155500     EISSN: 25337602     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Bulun, S. E., Economos, K., Miller, D., Simpson, E. R. (1994) CYP19 (aromatase cytochrome P450) gene expression in human malignant endometrial tumors. J. Clin. Endocrinol. Metabol. 79, 1831-1834.
2. Barrett-Conner, E., Bush, T. L. (1991) Estrogen and coronary heart disease in women. JAMA 265, 1861-1867.
3. Berstein, L. M., Imyatinov, E. N., Suspistin, E. N., Grigoriev, M. Y., Sokolov, E. P., Togo, A., Hanson, K. P., Poroshina, T. E., Vasiljev, D. A., Kovalevskij, A. Y., Gamajunova, V. B. (2001) CYP19 gene polymorphism in endometrial cancer patients. J. Cancer Res. Clin. Oncol. 127, 135-138.
4. Berstein, L. M., Imyatinov, E. N., Gamajunova, V. B., Kovalevskij, A. J., Kuligina, E. S., Belogubova, E. V., Buslov, K. G., Karpova, M. B., Togo, A. V., Volkov, O. N., Kovalenko, I. G. (2002) CYP17 genetic polymorphism in endometrial cancer: are only steroids involved? Cancer Lett. 180, 47-53.
5. Carani, C., Qin, K., Simoni, M., Faustini-Fustini, M., Serpente, S., Boyd, J., Korach, S. K., Simpson, E. R. (1997) Effect of testosterone and estradiol in a man with aromatase deficiency. N. Engl. J. Med. 337, 91-95.
6. Cauley, J. A., Gutani, J. P., Glynn, N. W., Paternostro-Bayles, M., Cottington, E., Kuller, L. H. (1992) Serum estrone concentrations and coronary artery disease in postmenopausal women. Arterioscler. Thromb. 14, 14-18.
7. Feigelson, H. S., Coetzee, G. A., Kolonel, L. N., Ross, R. K., Henderson, B. E. (1997) A polymorphism in the CYP17 gene increases the risk of breast cancer. Cancer Res. 57, 1063-1065.
8. Feigelson, H., Shames, L. S., Pike, M. C., Coetzee, G. A., Stanczyk, F. Z., Henderson, B. E. (1998) Cytochrome P450c17α gene (CYP17) polymorphism is associated with serum estrogen and progesterone concentration. Cancer Res. 58, 585-587.
9. Haiman, C. A., Hankinson, S. E., Speizer, F. E., Hunter, D. J. (1999) A tetranucleotide repeat polymorphism in CYP19 and breast cancer risk. Proc. Am. Assoc. Cancer Res. 40, 19.
10. Haiman, C. A., Hankinson, S. E., Spiegelman, D., Colditz, G. A., Willett, W. C., Speizer, F. E., Kelsey, T. K., Hunter, D. J. (1999) The relationship between a polymorphism in CYP17 with plasma hormone levels and breast cancer. Cancer Res. 59, 1015-1020.
11. Haiman, C. A., Stampfer, M. J., Giovannucci, E., Ma, J., Decalo, N. E., Kantoff, P. W., Hunter, D. J. (2001) The relationship between a polymorphism in CYP17 with plasma hormone levels and prostate cancer. Cancer Epidemiol. Biomarkers Prev. 10, 743-748.
12. Harada, N., Sasano, H., Murakami, H., Ohkuma, T., Nagura, H., Takagi, Y. (1999) Localized expression of aromatase in human vascular tissues. Circ. Res. 84, 1285-1291.
13. Healey, C. S., Dunning, A. M., Durocher, F., Teare, D., Pharoah, P. D., Luben, R. N., Easton, D. F., Ponder, B. A. (2000) Polymorphism in the human aromatase cytochrome P450 gene (CYP19) and breast cancer risk. Carcinogenesis 21, 189-193.
14. Kadonaga, J. T., Jones, K. A., Tjian, R. (1986) Promoter-specific activation of RNA polymerase II transcription by SpI. Trends Biochem. Sci. 11, 20-23.
15. Knopp, R. H. (1998) Cardiovascular effects of endogenous and exogenous sex hormones over a woman's lifetime. Am. J. Obstet. Gynecol. 158, 1630-1643.
16. Kuligana, E. S., Togo, A. V., Sispitsin, E. N., Grigorjev, M. Y., Pozharisskiy, K. M., Chagunava, O. L., Bernstein, L. M., Theilet, C., Hanson, K. P., Imyanitov, E. N. (2000) CYP17 polymorphism in the group of distinct breast cancer susceptibility: comparison of patients with the bilateral vs. monolateral breast cancer patients vs. middle-aged female controls vs. elderly tumor-free women. Cancer Lett. 156, 45-50.
17. Lea, C. K., Ebrahim, H., Tennant, S., Flanagan, A. M. (1997) Aromatase cytochrome P450 transcripts are detected in fractured human bone but not in normal skeletal tissue. Bone 21, 433-440.
18. Mendelson, M., Karas, R. (1999) The protective effects of estrogen on the cardiovascular system. N. Engl. J. Med. 340, 1801-1811.
19. Miller, W. L. (1988) Molecular biology of steroid hormone synthesis. Endocr. Rev. 9, 295-318.
20. Miller, W. R. (1996) Estrogen and breast cancer. Landes, Austin, pp. 207.
21. Murakami, H., Harada, N., Sasano, H. (2001) Aromatase in atherosclerotic lesions of human aorta. J. Steroid Biochem. Mol. Biol. 79, 67-74.
22. Nakajin, S., Shivley, J. E., Yuan, P., Hall, P. F. (1981) Microsomal cytochrome P-450 from neonatal pig testis. Two enzymatic activites (17α-hydroxylase and C17,20 lyase) associated with one protein. Biochemistry 20, 4037-4042.
23. Phillips, G. B., Pinkernell, B. H., Jing, T. J. (1994) The association of hypotestosteronemia with coronary artery disease in men. Arterioscler. Thromb. 14, 701-706.
24. Poglajen, G., Kirbis, J., Milutinovic A. (2004) The -455G/A polymorphism of the β fibrinogen gene and the Bgl 11 polymorphism of the α2β1 integrin gene and myocardial infarction in patients with type 2 diabetes. Folia Biol. (Praha) 50, 203-204.
25. Sasano, H., Harada, N. (1998) Intratumoral aromatase in human breast, endometrial, and ovarian malignancies. Endocrine Rev. 19, 593-607.
26. Wadelius, M., Anderson, A. O., Johanson, J. E., Wadelius, C., Rane, E. (1999) Prostate cancer associated with CYP17 genotype. Pharmacogenetics 9, 635-639.